Medtronic (NYSE:MDT) today said the FDA cleared its Euphora semicompliant balloon dilation catheter, and the company wasted no time in getting the pre-stenting device on the U.S. market.
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
TAVI: U.K. study finds 60% survival rate at 3 years
Surprise CE Mark for Stentys Xposition S stent
Stentys this week said it won a CE Mark ahead of schedule for its latest self-apposing coronary stent, a product that will be used with delivery system technology it acquired last June.
Maquet’s TigerPaw II recall is Class I
Contego Medical raises $6m for embolic filter tech
Tendyne mitral valve study launches in U.S.
Tendyne Holdings this month said its transcatheter mitral valve implant was implanted in the 1st U.S. patient as part of a global feasibility study.
TAVI: Edwards CEO says Sapien 3 could hit U.S. market this year
Sunshine Heart can resume trial after FDA OKs ‘minor’ changes
LVADs: Leviticus Cardio raises $1.5m for wireless power tech
CardiAQ Valve wins FDA nod for mitral valve trial
CardiAQ Valve Technologies today said it won a nod from the FDA for an early feasibility trial of its 2nd-generation transcatheter mitral valve implant.